|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 413 NORTH LEE STREET |
Address2 | P.O. BOX 1417-DR49 |
City | ALEXANDRIA |
State | VA |
Zip Code | 22313 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 26672-12
|
||||||||
|
6. House ID# 302390000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: R. James Huber, Senior Vice President, Finance |
Date | 07/17/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
See addendum.
H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan.
H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program.
H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals.
H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products.
H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program.
H.R.3140, Saving Our Community Pharmacies Act, as related to Medicaid provider reimbursement.
H.R.3193, Access to Community Pharmacy Preservation Act, as related to Medicaid provider reimbursement.
H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program.
H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices.
H.R.5491, Emilys Act, as related to the certification of pharmacy technicians.
H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices.
H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program.
H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals.
H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program.
H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals.
H.R.6252, Medicare DMEPOS Competitive Acquisition Reform Act of 2008, as related to provider participation in the Medicare competitive bidding program.
H.R.6331, the Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement, electronic health care, and Medicare programs.
H.R.6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies.
H.R.6357, PRO(TECH)T Act of 2008, as related to health information technology.
S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines.
S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies.
S.1693, Wired for Health Care Quality Act, as related to health information technology.
S.1695, the Biologics Price Competition and Innovation Act, as related to the approval of generic biopharmaceuticals.
S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program.
S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals.
S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program.
S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies.
S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program.
S.2071, Combat Methamphetamine Enhancement Act, as related to the distributio of legal substances used in the production of methamphetamine.
S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan.
S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program.
S.2978, Credit and Debit Card Receipt Clarification Act of 2008, as related to fair credit card practices
S.3001, National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program.
S.3086, Credit Card Fair Fee Act of 2008, as related to fair credit card practices.
S.3101, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement and electronic health care.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Justice - Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), President of the U.S., Federal Trade Commission (FTC),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steve |
Anderson |
|
|
|
Carol |
Kelly |
|
|
|
Paul |
Kelly |
|
|
|
Julie |
Khani |
|
|
|
Yong |
Choe |
|
|
|
Kate |
Fry |
|
|
|
Kevin |
Nicholson |
|
|
|
Diane |
Darvey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: List of membership available at http://www.nacds.org/wmspage.cfm?parm1=4921
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |